Renew Medical Launches New Solution to Help Prevent Accidental Bowel Leakage
May 18, 2016 09:00 ET
|
Renew Medical
FOSTER CITY, CA--(Marketwired - May 18, 2016) - Renew Medical Inc. (Renew) announced today the U.S. launch of the Renew Insert, an innovative silicone rectal insert device now available by...
CDx Diagnostics to Unveil New Data Demonstrating a Significant Advance in the Prevention of the Most Rapidly Growing Cancer in the U.S.
May 17, 2016 09:00 ET
|
CDx Diagnostics
SUFFERN, NY--(Marketwired - May 17, 2016) - CDx Diagnostics today announced that results from a multi-center, prospective, randomized clinical trial demonstrating that WATS3D (Wide Area...
PROMISE Trial Substudy Demonstrates That the Corus CAD Blood Test Is Associated With Clinical Events Among Patients Being Evaluated for Suspected Obstructive Coronary Artery Disease
April 04, 2016 08:30 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Apr 4, 2016) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a genomic substudy of the...
Commentary in The American Journal of Medicine Reinforces the Value of the Corus CAD Test in Evaluating Symptomatic Patients With Suspected Obstructive Coronary Artery Disease
March 02, 2016 08:30 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Mar 2, 2016) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today that a Commentary entitled A Novel...
Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer
December 14, 2015 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Dec 14, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the appointment of Timothy Henn as Chief...
Multi-Center, Community-Based Patient Registry Interim Results Presented at the AHA Scientific Sessions Support the Clinical Utility of the Corus(R) CAD Test in the Assessment of Obstructive Coronary Artery Disease
November 10, 2015 08:11 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Nov 10, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a multi-center,...
New Data Presented at UEG Week Shows Use of WATS3D Significantly Increases Detection of Esophageal Pre-Cancer
October 27, 2015 09:30 ET
|
CDx Diagnostics
BARCELONA, SPAIN--(Marketwired - Oct 27, 2015) - CDx Diagnostics today announced new data from a prospective multi-center community-based study demonstrating a significant increase in detection of...
Large Multi-Center Study Demonstrates Significant Increase in Detection of Esophageal Pre-Cancer With Use of WATS3D Biopsy
October 21, 2015 16:30 ET
|
CDx Diagnostics
HONOLULU, HI--(Marketwired - Oct 21, 2015) - CDx Diagnostics announced today new data from a prospective multi-center study of more than 12,800 patients demonstrating a significant increase in...
CDx Diagnostics to Present New Data Demonstrating Increased Detection of Esophageal Pre-Cancer Using WATS3D
October 14, 2015 10:03 ET
|
CDx Diagnostics
SUFFERN, NY--(Marketwired - Oct 14, 2015) - CDx Diagnostics today announced the presentation of results from a prospective multi-center study demonstrating that the WATS3D three dimensional...
CardioDx Announces Positive Data From a Large Primary Care Registry on the Impact of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease in Women
September 30, 2015 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Sep 30, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a subgroup analysis of the...